Acura Pharmaceuticals OTC Stock Forward View
| ACUR Stock | USD 0.0005 0.00 0.00% |
Acura OTC Stock outlook is based on your current time horizon.
As of today the value of rsi of Acura Pharmaceuticals' share price is below 20 . This suggests that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate signals. We use our internally-built news screening methodology to estimate the value of Acura Pharmaceuticals based on different types of headlines from major news networks to social media. Using Acura Pharmaceuticals hype-based prediction, you can estimate the value of Acura Pharmaceuticals from the perspective of Acura Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Acura Pharmaceuticals on the next trading day is expected to be 0.0005 with a mean absolute deviation of 0.00004 and the sum of the absolute errors of 0. Acura Pharmaceuticals after-hype prediction price | USD 5.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Acura |
Acura Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Acura price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Acura using various technical indicators. When you analyze Acura charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Acura Pharmaceuticals Naive Prediction Price Forecast For the 7th of February
Given 90 days horizon, the Naive Prediction forecasted value of Acura Pharmaceuticals on the next trading day is expected to be 0.0005 with a mean absolute deviation of 0.00004, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Acura OTC Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Acura Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Acura Pharmaceuticals OTC Stock Forecast Pattern
| Backtest Acura Pharmaceuticals | Acura Pharmaceuticals Price Prediction | Research Analysis |
Acura Pharmaceuticals Forecasted Value
In the context of forecasting Acura Pharmaceuticals' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Acura Pharmaceuticals' downside and upside margins for the forecasting period are 0.000005 and 24.64, respectively. We have considered Acura Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Acura Pharmaceuticals otc stock data series using in forecasting. Note that when a statistical model is used to represent Acura Pharmaceuticals otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 98.4735 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.1515 |
| SAE | Sum of the absolute errors | 0.0024 |
Predictive Modules for Acura Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acura Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acura Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acura Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Acura Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Acura Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Acura Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Acura Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Acura Pharmaceuticals' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Acura Pharmaceuticals' historical news coverage. Acura Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 24.64, respectively. We have considered Acura Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Acura Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Acura Pharmaceuticals is based on 3 months time horizon.
Acura Pharmaceuticals OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Acura Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acura Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Acura Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.06 | 24.64 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0005 | 0.0005 | 0.00 |
|
Acura Pharmaceuticals Hype Timeline
Acura Pharmaceuticals is presently traded for 0.0005. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Acura is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 2.06%. %. The volatility of related hype on Acura Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 19.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 125.0. Acura Pharmaceuticals recorded a loss per share of 0.03. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 28th of August 2015. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Acura Pharmaceuticals to cross-verify your projections.Acura Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Acura Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Acura Pharmaceuticals' future price movements. Getting to know how Acura Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Acura Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FLHLF | Filament Health Corp | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 99.50 | |
| TNPH | Tianan Pharmaceutical Co | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 317.02 | |
| KALY | Kali Inc | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | |
| CBDX | Curative Biosciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NNRX | Nutranomics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AZFL | Amazonas Florestal | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MRRCF | Wayland Group Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CNBX | Cannabics Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GNLKQ | Genelink | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GMVDF | G Medical Innovations | 0.00 | 0 per month | 0.00 | 0.10 | 0.00 | (50.00) | 1,096 |
Other Forecasting Options for Acura Pharmaceuticals
For every potential investor in Acura, whether a beginner or expert, Acura Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Acura OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Acura. Basic forecasting techniques help filter out the noise by identifying Acura Pharmaceuticals' price trends.Acura Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acura Pharmaceuticals otc stock to make a market-neutral strategy. Peer analysis of Acura Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Acura Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Acura Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Acura Pharmaceuticals otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acura Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Acura Pharmaceuticals otc stock market strength indicators, traders can identify Acura Pharmaceuticals entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 5.0E-4 | |||
| Day Typical Price | 5.0E-4 |
Story Coverage note for Acura Pharmaceuticals
The number of cover stories for Acura Pharmaceuticals depends on current market conditions and Acura Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Acura Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Acura Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Additional Tools for Acura OTC Stock Analysis
When running Acura Pharmaceuticals' price analysis, check to measure Acura Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acura Pharmaceuticals is operating at the current time. Most of Acura Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acura Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acura Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acura Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.